1.
Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study
by Grant, Robert M, Prof
The Lancet infectious diseases, 2014, Vol.14 (9), p.820-829
2.
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration
by Smith, Colette J, Dr
The Lancet (British edition), 2014, Vol.384 (9939), p.241-248
3.
The end of AIDS: HIV infection as a chronic disease
by Deeks, Steven G, Prof
The Lancet (British edition), 2013, Vol.382 (9903), p.1525-1533
4.
The cryoglobulinaemias
by Ramos-Casals, Manuel, MD
The Lancet (British edition), 2012, Vol.379 (9813), p.348-360
5.
Estimating per-act HIV transmission risk: a systematic review
by Patel, Pragna
AIDS (London), 2014-06-19, Vol.28 (10), p.1509-1519
6.
Burden of HIV among female sex workers in low-income and middle-income countries: a systematic review and meta-analysis
by Baral, Stefan, Dr
The Lancet infectious diseases, 2012, Vol.12 (7), p.538-549
7.
Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection
by HRABER, Peter
AIDS (London), 2014, Vol.28 (2), p.163-169
8.
HIV-associated neurocognitive disorder
by Clifford, David B, Prof
The Lancet infectious diseases, 2013, Vol.13 (11), p.976-986
9.
Worldwide burden of HIV in transgender women: a systematic review and meta-analysis
by Baral, Stefan D, Dr
The Lancet infectious diseases, 2013, Vol.13 (3), p.214-222
10.
Clinical picture and treatment of 2212 patients with common variable immunodeficiency
by Gathmann, Benjamin, MA
Journal of allergy and clinical immunology, 2014, Vol.134 (1), p.116-126.e11
11.
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cel...
by Cavo, Michele, Prof
The Lancet (British edition), 2010, Vol.376 (9758), p.2075-2085
12.
Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial
by Grinsztejn, Beatriz, MD
The Lancet infectious diseases, 2014, Vol.14 (4), p.281-290
13.
Loss of integrin αvβ8 on dendritic cells causes autoimmunity and colitis in mice
by TRAVIS, Mark A
Nature (London), 2007, Vol.449 (7160), p.361-365
14.
Comparisons of disparities and risks of HIV infection in black and other men who have sex with men in Canada, UK, and USA: a meta-analysis
by Millett, Gregorio A, MPH
The Lancet (British edition), 2012, Vol.380 (9839), p.341-348
15.
Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy
by MAY, Margaret T
AIDS (London), 2014, Vol.28 (8), p.1193-1202
16.
Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS
by PARK, Benjamin J
AIDS (London), 2009, Vol.23 (4), p.525-530
17.
Perinatally acquired HIV infection in adolescents from sub-Saharan Africa: a review of emerging challenges
by Lowenthal, Elizabeth D, MD
The Lancet infectious diseases, 2014, Vol.14 (7), p.627-639
18.
First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial
by Morgan, Gareth J, Dr, Prof
The Lancet (British edition), 2010, Vol.376 (9757), p.1989-1999
19.
Natural killer cell deficiency
by Orange, Jordan S., MD, PhD
Journal of allergy and clinical immunology, 2013, Vol.132 (3), p.515-525
20.
Induction of a Chronic Disease State in Patients With Smoldering or Indolent Multiple Myeloma by Targeting Interleukin 1β-Induced Interleukin 6 Production and the Myeloma Prolifera...
by Lust, John A., MD, PhD
Mayo Clinic proceedings, 2009, Vol.84 (2), p.114-122
